selected publications
-
Living Cell Materials for Advanced Biomedical Applications in Disease Diagnosis, Treatment, and Prevention.
Advanced healthcare materials.
2025
Information Resource
GET IT
Times cited: 1 -
Surface-functionalized bacteria: Frontier explorations in next-generation live biotherapeutics.
Biomaterials.
2024
Information Resource
GET IT
Times cited: 19 -
Spatiotemporally-controlled hydrophobic drug delivery via photosensitizer-driven assembly-disassembly for enhanced triple-negative breast cancer treatment.
Journal of controlled release : official journal of the Controlled Release Society.
2024
Academic Article
GET IT
Times cited: 11 -
Emerging albumin hydrogels as personalized biomaterials.
Acta biomaterialia.
2022
Information Resource
GET IT
Times cited: 39 -
Dual-Stage Irradiation of Size-Switchable Albumin Nanocluster for Cascaded Tumor Enhanced Penetration and Photothermal Therapy.
ACS nano.
2022
Academic Article
GET IT
Times cited: 64 -
Living Cell Nanoporation and Exosomal RNA Analysis Platform for Real-Time Assessment of Cellular Therapies.
Journal of the American Chemical Society.
2022
Academic Article
GET IT
Times cited: 23 -
Bioinspired Cell Silicification: From Extracellular to Intracellular.
Journal of the American Chemical Society.
2021
Academic Article
GET IT
Times cited: 68 -
Optimization and characterization of poly(lactic-co-glycolic acid) nanoparticles loaded with astaxanthin and evaluation of anti-photodamage effect in vitro.
Royal Society open science.
2019
Academic Article
GET IT
Times cited: 59 -
Resveratrol loaded oxidized mesoporous carbon nanoparticles: A promising tool to treat triple negative breast cancer.
Biochemical and biophysical research communications.
2019
Academic Article
GET IT
Times cited: 33 -
5-hydroxymethylfurfural-embedded poly (vinyl alcohol)/sodium alginate hybrid hydrogels accelerate wound healing.
International journal of biological macromolecules.
2019
Academic Article
GET IT
Times cited: 84 -
CD30 aptamer-functionalized PEG-PLGA nanoparticles for the superior delivery of doxorubicin to anaplastic large cell lymphoma cells.
International journal of pharmaceutics.
2019
Academic Article
GET IT
Times cited: 31 -
5-Hydroxymethylfurfural Mitigates Lipopolysaccharide-Stimulated Inflammation via Suppression of MAPK, NF-κB and mTOR Activation in RAW 264.7 Cells.
Molecules (Basel, Switzerland).
2019
Academic Article
GET IT
Times cited: 98